General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0NHUBS
ADC Name
BsAb-ADC (Medilink Therapeutics)
Organization
Suzhou Medilink Therapeutics Ltd.
Drug Status
Clinical candidate
Indication
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.